{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:25:32Z","timestamp":1789097132151,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR11RA063"],"award-info":[{"award-number":["22JR11RA063"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["2021620005003633"],"award-info":[{"award-number":["2021620005003633"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012899","name":"Lanzhou University","doi-asserted-by":"publisher","award":["2021620005003632"],"award-info":[{"award-number":["2021620005003632"]}],"id":[{"id":"10.13039\/100012899","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.mvr.2025.104847","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T23:10:12Z","timestamp":1753398612000},"page":"104847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["PCSK9 inhibitor improved cardiac function after acute myocardial infarction in rats"],"prefix":"10.1016","volume":"162","author":[{"given":"Hongjin","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junju","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mvr.2025.104847_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051440","article-title":"Naturally occurring PCSK9 inhibitors","volume":"12","author":"Adorni","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.mvr.2025.104847_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.602497","article-title":"PCSK9 in myocardial infarction and cardioprotection: importance of lipid metabolism and inflammation","volume":"11","author":"Andreadou","year":"2020","journal-title":"Front. Physiol."},{"issue":"13","key":"10.1016\/j.mvr.2025.104847_bb0015","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1111\/jcmm.16460","article-title":"miR-126-3p is essential for CXCL12-induced angiogenesis","volume":"25","author":"Bassand","year":"2021","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.mvr.2025.104847_bb0020","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5301","article-title":"Role of RIPK3-CaMKII-mPTP signaling pathway-mediated necroptosis in cardiovascular diseases (review)","volume":"52","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.mvr.2025.104847_bb0025","doi-asserted-by":"crossref","first-page":"H359","DOI":"10.1152\/ajpheart.00476.2021","article-title":"Quantification of murine myocardial infarct size using 2-D and 4-D high-frequency ultrasound","volume":"322","author":"Dann","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"21","key":"10.1016\/j.mvr.2025.104847_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218174","article-title":"The role of RIPK1 and RIPK3 in cardiovascular disease","volume":"21","author":"DeRoo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.mvr.2025.104847_bb0035","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/cvr\/cvy128","article-title":"PCSK9 expression in the ischaemic heart and its relationship to infarct size, cardiac function, and development of autophagy","volume":"114","author":"Ding","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.mvr.2025.104847_bb0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1373\/clinchem.2017.283887","article-title":"Evaluating rapid rule-out of acute myocardial infarction using a high-sensitivity cardiac troponin I assay at presentation","volume":"64","author":"Greenslade","year":"2018","journal-title":"Clin. Chem."},{"key":"10.1016\/j.mvr.2025.104847_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.712061","article-title":"Association of circulating, inflammatory-response exosomal mRNAs with acute myocardial infarction","volume":"8","author":"He","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.mvr.2025.104847_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.40","article-title":"Flow cytometric evaluation of the ongoing angiogenic response in rat cardiac tissue following myocardial infarction","volume":"1","author":"Hoeeg","year":"2021","journal-title":"Curr. Protoc."},{"issue":"13","key":"10.1016\/j.mvr.2025.104847_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136988","article-title":"Ca(2+)\/calmodulin-dependent protein kinase II regulation by inhibitor of receptor interacting protein kinase 3 alleviates necroptosis in glycation end products-induced cardiomyocytes injury","volume":"23","author":"Hua","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mvr.2025.104847_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104371","article-title":"PCSK9 inhibition protects against myocardial ischemia-reperfusion injury via suppressing autophagy","volume":"142","author":"Huang","year":"2022","journal-title":"Microvasc. Res."},{"issue":"3","key":"10.1016\/j.mvr.2025.104847_bb0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jjcc.2023.05.003","article-title":"In-hospital predictors for primary prevention of sudden death after acute myocardial infarction with cardiac dysfunction","volume":"82","author":"Konagai","year":"2023","journal-title":"J. Cardiol."},{"key":"10.1016\/j.mvr.2025.104847_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.762334","article-title":"Receptor interacting protein kinases 1\/3: the potential therapeutic target for cardiovascular inflammatory diseases","volume":"12","author":"Leng","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.mvr.2025.104847_bb0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13104-021-05900-5","article-title":"Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid","volume":"15","author":"Li","year":"2022","journal-title":"BMC. Res. Notes"},{"issue":"8","key":"10.1016\/j.mvr.2025.104847_bb0080","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00109-022-02231-1","article-title":"Aib1 deficiency exacerbates inflammatory responses in acute myocardial infarction mice","volume":"100","author":"Li","year":"2022","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.mvr.2025.104847_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172954","article-title":"Morroniside enhances angiogenesis and improves cardiac function following acute myocardial infarction in rats","volume":"872","author":"Liu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.mvr.2025.104847_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10020429","article-title":"Ceramides and cardiovascular risk factors, inflammatory parameters and left ventricular function in AMI patients","volume":"10","author":"Michelucci","year":"2022","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.mvr.2025.104847_bb0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14656566.2019.1702970","article-title":"PCSK9 inhibitors for treating hypercholesterolemia","volume":"21","author":"Pasta","year":"2020","journal-title":"Expert. Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.mvr.2025.104847_bb0100","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1302\/2046-3758.99.BJR-2020-0113.R1","article-title":"Pulsed electromagnetic fields improve the healing process of Achilles tendinopathy: a pilot study in a rat model","volume":"9","author":"Perucca Orfei","year":"2020","journal-title":"Bone & Joint Research"},{"issue":"4","key":"10.1016\/j.mvr.2025.104847_bb0105","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13459","article-title":"PCSK9 and atherosclerosis: looking beyond LDL regulation","volume":"51","author":"Ragusa","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.mvr.2025.104847_bb0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(19)30158-5","article-title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","volume":"7","author":"Ray","year":"2019","journal-title":"The Lancet Diabetes & endocrinology"},{"key":"10.1016\/j.mvr.2025.104847_bb0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.peptides.2018.05.001","article-title":"Galanin and its N-terminal fragments reduce acute myocardial infarction in rats","volume":"111","author":"Serebryakova","year":"2019","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.mvr.2025.104847_bb0120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.34172\/apb.2020.062","article-title":"PCSK9: a key target for the treatment of cardiovascular disease (CVD)","volume":"10","author":"Sobati","year":"2020","journal-title":"Advanced Pharmaceutical Bulletin"},{"issue":"1","key":"10.1016\/j.mvr.2025.104847_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14712598.2020.1677604","article-title":"PCSK9 inhibitors and cardiovascular outcomes","volume":"20","author":"Steffens","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.mvr.2025.104847_bb0130","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1007\/s00018-020-03738-x","article-title":"Contribution of cell death signaling to blood vessel formation","volume":"78","author":"Tisch","year":"2021","journal-title":"Cellular and Molecular Life Sciences: CMLS"},{"key":"10.1016\/j.mvr.2025.104847_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.696362","article-title":"RIP1\/RIP3\/MLKL mediates myocardial function through necroptosis in experimental autoimmune myocarditis","volume":"8","author":"Wu","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"9","key":"10.1016\/j.mvr.2025.104847_bb0140","first-page":"1096","article-title":"Changes in plasma levels of RIPK1, RIPK3, and MLKL in patients with coronary atherosclerotic heart disease and its clinical predictive value","volume":"45","author":"Xiao","year":"2020","journal-title":"Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences"},{"issue":"3(Special)","key":"10.1016\/j.mvr.2025.104847_bb0145","first-page":"973","article-title":"Nitroglycerin plus clopidogrel for acute myocardial infarction and the effect on cardiac function indices","volume":"36","author":"Xie","year":"2023","journal-title":"Pak. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.mvr.2025.104847_bb0150","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.numecd.2020.11.010","article-title":"PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction","volume":"31","author":"Zeller","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.mvr.2025.104847_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12944-020-01280-0","article-title":"Metabolic effects of PCSK9 inhibition with Evolocumab in subjects with elevated Lp(a)","volume":"19","author":"Zhang","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"39","key":"10.1016\/j.mvr.2025.104847_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030621","article-title":"A novel necroptosis-related lncRNAs signature for survival prediction in clear cell renal cell carcinoma","volume":"101","author":"Zhao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.mvr.2025.104847_bb0165","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635955","article-title":"RIPK3 induces cardiomyocyte necroptosis via inhibition of AMPK-Parkin-mitophagy in cardiac remodelling after myocardial infarction","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286225000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286225000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T20:01:41Z","timestamp":1757188901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286225000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":33,"alternative-id":["S0026286225000664"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2025.104847","relation":{},"ISSN":["0026-2862"],"issn-type":[{"value":"0026-2862","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 inhibitor improved cardiac function after acute myocardial infarction in rats","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2025.104847","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104847"}}